title: Thiopurines best practice.
authors.affiliation: The Alfred Hospital and Monash University, Melbourne, Victoria, Australia. A.Friedman@alfred.org.au.
authors.forename: Antony
authors.initials: A
authors.lastname: Friedman
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D004359:Drug Therapy, Combination; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000378:metabolism; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D012074:Remission Induction; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D006454:Hemoglobins; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein; C543529:vedolizumab; D015122:Mercaptopurine; D001379:Azathioprine